يعرض 1 - 10 نتائج من 180 نتيجة بحث عن '"David R. Staskin"', وقت الاستعلام: 1.04s تنقيح النتائج
  1. 1
    Efficacy and Safety of Once-Daily Vibegron for Treatment of Overactive Bladder in Patients Aged ≥65 and ≥75 Years: Subpopulation Analysis from the EMPOWUR Randomized, International, Phase III Study

    المؤلفون: Jeffrey Frankel, David R. Staskin, Susann Varano, Rachael Jankowich, Denise Shortino, Paul N. Mudd

    المصدر: Drugs & Aging

    مصطلحات موضوعية: medicine.medical_specialty, Pyrrolidines, Population, Pyrimidinones, Placebo, 03 medical and health sciences, 0302 clinical medicine, Pharmacotherapy, Double-Blind Method, Internal medicine, medicine, Humans, Pharmacology (medical), In patient, 030212 general & internal medicine, Original Research Article, Adverse effect, education, Aged, education.field_of_study, business.industry, Urinary Bladder, Overactive, medicine.disease, Clinical trial, Treatment Outcome, Overactive bladder, Tolterodine, Geriatrics and Gerontology, business, 030217 neurology & neurosurgery, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f13652957bd5e6219fee7bf4b3d0785Test
    http://europepmc.org/articles/PMC7882560Test


    أضف إلى المفضلة
  2. 2
    Safety and Tolerability Results from the PILLAR Study: A Phase IV, Double-Blind, Randomized, Placebo-Controlled Study of Mirabegron in Patients ≥ 65 years with Overactive Bladder-Wet

    المؤلفون: Adrian Wagg, David R. Staskin, Sender Herschorn, Carol R. Schermer, Rita M Kristy

    المصدر: Drugs & Aging

    مصطلحات موضوعية: Diarrhea, Male, medicine.medical_specialty, Placebo-controlled study, Adrenergic beta-3 Receptor Agonists, Placebo, Severity of Illness Index, law.invention, 03 medical and health sciences, 0302 clinical medicine, Double-Blind Method, Randomized controlled trial, law, Internal medicine, medicine, Humans, Pharmacology (medical), Original Research Article, 030212 general & internal medicine, Adverse effect, Aged, Dose-Response Relationship, Drug, Urinary Bladder, Overactive, business.industry, Age Factors, Headache, Middle Aged, medicine.disease, Clinical trial, Thiazoles, Treatment Outcome, Urinary Incontinence, Tolerability, Overactive bladder, Acetanilides, Female, Geriatrics and Gerontology, Mirabegron, business, 030217 neurology & neurosurgery, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::952cabf2e7ecf15f6f4812d7ae1a0624Test
    https://doi.org/10.1007/s40266-020-00783-wTest


    أضف إلى المفضلة
  3. 3
    Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo

    المؤلفون: Nurul Choudhury, Sender Herschorn, Matthias Stoelzel, John Heesakkers, Christopher R. Chapple, Linda Cardozo, Francisco Cruz, Emad Siddiqui, David R. Staskin

    المصدر: European Urology, 77, 119-128
    European Urology, 77, 1, pp. 119-128
    Transl Androl Urol

    مصطلحات موضوعية: Male, medicine.medical_specialty, Databases, Factual, Tolterodine Tartrate, Urology, 030232 urology & nephrology, MEDLINE, Adrenergic beta-3 Receptor Agonists, Muscarinic Antagonists, Placebo, 03 medical and health sciences, 0302 clinical medicine, All institutes and research themes of the Radboud University Medical Center, Double-Blind Method, Internal medicine, medicine, Nocturia, Humans, Medical history, Aged, Solifenacin, Urinary Bladder, Overactive, business.industry, Solifenacin Succinate, Middle Aged, medicine.disease, Clinical trial, Thiazoles, Editorial Commentary, Treatment Outcome, Reconstructive and regenerative medicine Radboud Institute for Molecular Life Sciences [Radboudumc 10], Reproductive Medicine, Overactive bladder, 030220 oncology & carcinogenesis, Acetanilides, Female, Tolterodine, medicine.symptom, Mirabegron, business, medicine.drug

    وصف الملف: application/pdf

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3f9a28e569df1a3a10395e6350312a6Test
    https://doi.org/10.1016/j.eururo.2019.09.024Test


    أضف إلى المفضلة
  4. 4
    Efficacy and Safety of Combination Pharmacotherapy for Patients with Overactive Bladder: A Rapid Evidence Assessment

    المؤلفون: Christopher R. Chapple, Elizabeth R. Mueller, Emad Siddiqui, Christian Gratzke, Matthias Stoelzel, Dudley Robinson, Catherine Rolland, David R. Staskin, Rob van Maanen

    المصدر: European Urology. 76:767-779

    مصطلحات موضوعية: medicine.medical_specialty, Urology, 030232 urology & nephrology, Adrenergic beta-3 Receptor Agonists, Context (language use), Muscarinic Antagonists, Placebo, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, medicine, Clinical endpoint, Humans, Randomized Controlled Trials as Topic, Solifenacin, Urinary Bladder, Overactive, business.industry, medicine.disease, Treatment Outcome, Overactive bladder, 030220 oncology & carcinogenesis, Drug Therapy, Combination, Propiverine, Mirabegron, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58b8c2d9538d23465f5739711a5bd465Test
    https://doi.org/10.1016/j.eururo.2019.07.010Test


    أضف إلى المفضلة
  5. 5
    MP63-15 VIBEGRON FOR THE TREATMENT OF PATIENTS WITH DRY OVERACTIVE BLADDER: A SUBGROUP ANALYSIS FROM THE EMPOWUR TRIAL

    المؤلفون: Michael Kennelly, David R. Staskin, Paul N. Mudd, Matt T. Rosenberg, Denise Shortino, Susann Varano, Jeffrey Frankel, Rachael Jankowich, Diane K. Newman

    المصدر: Journal of Urology. 206

    مصطلحات موضوعية: medicine.medical_specialty, Urinary urgency, Urge urinary incontinence, business.industry, Urology, Subgroup analysis, urologic and male genital diseases, medicine.disease, female genital diseases and pregnancy complications, Overactive bladder, medicine, Nocturia, medicine.symptom, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::851091d4e2b0ab0fbd7a0b3ac0402923Test
    https://doi.org/10.1097/ju.0000000000002103.15Test


    أضف إلى المفضلة
  6. 6
    Vibegron improves quality‐of‐life measures in patients with overactive bladder: Patient‐reported outcomes from the EMPOWUR study

    المؤلفون: Jeffrey Frankel, Susann Varano, Denise Shortino, Paul N. Mudd, David R. Staskin, Rachael Jankowich

    المصدر: International Journal of Clinical Practice

    مصطلحات موضوعية: medicine.medical_specialty, Pyrrolidines, Tolterodine Tartrate, Urology, Muscarinic Antagonists, Pyrimidinones, 030204 cardiovascular system & hematology, Placebo, urologic and male genital diseases, 03 medical and health sciences, 0302 clinical medicine, Double-Blind Method, Internal medicine, medicine, Humans, In patient, 030212 general & internal medicine, Patient Reported Outcome Measures, Original Paper, business.industry, Urinary Bladder, Overactive, General Medicine, medicine.disease, Highly selective, Original Papers, female genital diseases and pregnancy complications, humanities, Clinical trial, Treatment Outcome, Overactive bladder, Quality of Life, Tolterodine, Extended release, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5d3fd90f6cfa035be4373072df3fad0Test
    http://europepmc.org/articles/PMC8244055Test


    أضف إلى المفضلة
  7. 7
    Once-Daily Vibegron 75 mg for Overactive Bladder: Long-Term Safety and Efficacy from a Double-Blind Extension Study of the International Phase 3 Trial (EMPOWUR)

    المؤلفون: Paul N. Mudd, Rachael Jankowich, David R. Staskin, Susann Varano, Denise Shortino, Jeffrey Frankel

    المصدر: The Journal of urology. 205(5)

    مصطلحات موضوعية: Male, medicine.medical_specialty, Pyrrolidines, Time Factors, Tolterodine Tartrate, Urology, media_common.quotation_subject, 030232 urology & nephrology, Urinary incontinence, Muscarinic Antagonists, Pyrimidinones, Urination, Drug Administration Schedule, Double blind, 03 medical and health sciences, 0302 clinical medicine, Double-Blind Method, medicine, Humans, media_common, Aged, Urinary bladder, business.industry, Urinary Bladder, Overactive, Extension study, Middle Aged, medicine.disease, medicine.anatomical_structure, Treatment Outcome, Tolerability, Overactive bladder, Physical therapy, Female, Long term safety, medicine.symptom, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c90ad140865404fbde0459037fab8a0Test
    https://pubmed.ncbi.nlm.nih.gov/33687276Test


    أضف إلى المفضلة
  8. 8
    International Phase III, Randomized, Double-Blind, Placebo and Active Controlled Study to Evaluate the Safety and Efficacy of Vibegron in Patients with Symptoms of Overactive Bladder: EMPOWUR

    المؤلفون: David R. Staskin, Denise Shortino, Rachael Jankowich, Paul N. Mudd, Susann Varano, Jeffrey Frankel

    المصدر: The Journal of urology. 204(2)

    مصطلحات موضوعية: Agonist, Adult, Male, medicine.medical_specialty, Internationality, Pyrrolidines, Tolterodine Tartrate, medicine.drug_class, Urology, 030232 urology & nephrology, Adrenergic beta-3 Receptor Agonists, Urinary incontinence, Pyrimidinones, Placebo, Double blind, 03 medical and health sciences, 0302 clinical medicine, Double-Blind Method, medicine, Humans, Aged, Urinary bladder, business.industry, Urinary Bladder, Overactive, Middle Aged, medicine.disease, medicine.anatomical_structure, Tolerability, Overactive bladder, Delayed-Action Preparations, Urological Agents, Female, medicine.symptom, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a21b399a0841328deac6449e0ecea72Test
    https://pubmed.ncbi.nlm.nih.gov/32436759Test


    أضف إلى المفضلة
  9. 9
    Efficacy and Safety of Mirabegron versus Placebo Add-On Therapy in Men with Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Randomized, Phase 4 Study (PLUS)

    المؤلفون: David R. Staskin, Kevin T. McVary, Sender Herschorn, Christopher R. Chapple, John Hairston, Steven A. Kaplan, Steve Foley, Nurul Choudhury, Carol R. Schermer, Javier Cambronero Santos, Rita M Kristy

    المساهمون: CHU Pontchaillou [Rennes]

    المصدر: Journal of Urology
    Journal of Urology, Elsevier, 2020, 203 (6), pp.1171-1171. ⟨10.1097/ju.0000000000000738.01⟩

    مصطلحات موضوعية: Adult, Male, Tamsulosin, medicine.medical_specialty, Urology, [SDV]Life Sciences [q-bio], 030232 urology & nephrology, Prostatic Hyperplasia, Placebo, Drug Administration Schedule, 03 medical and health sciences, 0302 clinical medicine, Double-Blind Method, Lower urinary tract symptoms, Medicine, Humans, ComputingMilieux_MISCELLANEOUS, Aged, Aged, 80 and over, Urinary bladder, business.industry, Urinary Bladder, Overactive, Hyperplasia, Middle Aged, medicine.disease, Add on therapy, Thiazoles, medicine.anatomical_structure, Treatment Outcome, Overactive bladder, Urological Agents, Acetanilides, Drug Therapy, Combination, business, Mirabegron, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9120fbe0f5a8161fe87a79b60473390Test
    https://hal.archives-ouvertes.fr/hal-03228620Test


    أضف إلى المفضلة
  10. 10
    Patient-reported outcomes in patients with overactive bladder treated with mirabegron and tolterodine in a prospective, double-blind, randomized, two-period crossover, multicenter study (PREFER)

    المؤلفون: Carol R. Schermer, Sender Herschorn, David R. Staskin, Katherine Gooch, Le Mai Tu, Terry Walsh, Jonathan Fialkov

    المصدر: Health and Quality of Life Outcomes, Vol 16, Iss 1, Pp 1-12 (2018)
    Health and Quality of Life Outcomes

    مصطلحات موضوعية: Male, Health-related quality of life, 030232 urology & nephrology, urologic and male genital diseases, OAB-questionnaire, 0302 clinical medicine, Prospective Studies, Prospective cohort study, 030219 obstetrics & reproductive medicine, Cross-Over Studies, General Medicine, Middle Aged, female genital diseases and pregnancy complications, humanities, Overactive bladder, Tolerability, Patient Satisfaction, Urological Agents, lcsh:R858-859.7, Female, Tolterodine, medicine.drug, Adult, medicine.medical_specialty, Tolterodine Tartrate, lcsh:Computer applications to medicine. Medical informatics, 03 medical and health sciences, Patient Perception of Bladder Condition, Patient satisfaction, Double-Blind Method, Internal medicine, medicine, Humans, Patient Reported Outcome Measures, Aged, Mirabegron, Patient-reported outcomes, business.industry, Urinary Bladder, Overactive, Research, Public Health, Environmental and Occupational Health, medicine.disease, Crossover study, Thiazoles, Tolterodine ER, Quality of Life, OAB-satisfaction, Acetanilides, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::848d258c8661d7fb9b27748e24c14699Test
    http://link.springer.com/article/10.1186/s12955-018-0892-0Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث